Nanomedicine - Facts Sheet
Main Features of Genetic Immunity's Nanomedicine formulation are:
- Mimics the size, appearance and other features of a virus
- Protects the antigens from extra- and intracellular degradation
- Specifically targets antigens to dendritic cells
- Induces long-lasting immunological memory
- Well characterized according to regulatory requirements
- Cost-effective, reproducible, scalable manufacturing process
- Topical dendritic cell targeting administration with DermaPrep delivery device
Our Nanomedicine Vaccine product candidates are based on the Nanomedicine technology. A number of pre-clinical
and human clinical study have demonstrated the safety and immunogenicity of Nanomedicine. For example Genetic Immunity's
lead product candidate, the DermaVir Patch, is already in Phase II clinical trials using Nanomedicine.
www.geneticimmunity.com